196 related articles for article (PubMed ID: 32004775)
1. HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-β-d-glucuronide in human plasma.
Zheng Y; Aboura R; Boujaafar S; Lui G; Hirt D; Bouazza N; Foissac F; Treluyer JM; Benaboud S; Gana I
J Pharm Biomed Anal; 2020 Apr; 182():113119. PubMed ID: 32004775
[TBL] [Abstract][Full Text] [Related]
2. UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma.
Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A
J Pharm Biomed Anal; 2017 May; 138():223-230. PubMed ID: 28219799
[TBL] [Abstract][Full Text] [Related]
3. A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine.
Fayet A; Béguin A; Zanolari B; Cruchon S; Guignard N; Telenti A; Cavassini M; Günthard HF; Buclin T; Biollaz J; Rochat B; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1057-69. PubMed ID: 19332396
[TBL] [Abstract][Full Text] [Related]
4. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
[TBL] [Abstract][Full Text] [Related]
5. Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry.
Yamada E; Takagi R; Sudo K; Kato S
J Pharm Biomed Anal; 2015 Oct; 114():390-7. PubMed ID: 26112927
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samples.
Tsuchiya K; Ohuchi M; Yamane N; Aikawa H; Gatanaga H; Oka S; Hamada A
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28762239
[TBL] [Abstract][Full Text] [Related]
7. Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC-MS/MS.
Zheng Y; Lui G; Boujaafar S; Aboura R; Bouazza N; Foissac F; Treluyer JM; Benaboud S; Hirt D; Gana I
J Pharm Biomed Anal; 2021 Mar; 196():113923. PubMed ID: 33571728
[TBL] [Abstract][Full Text] [Related]
8. A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma.
Bennetto-Hood C; Tabolt G; Savina P; Acosta EP
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():225-32. PubMed ID: 24361860
[TBL] [Abstract][Full Text] [Related]
9. Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology.
Djerada Z; Feliu C; Tournois C; Vautier D; Binet L; Robinet A; Marty H; Gozalo C; Lamiable D; Millart H
J Pharm Biomed Anal; 2013 Dec; 86():100-11. PubMed ID: 23995753
[TBL] [Abstract][Full Text] [Related]
10. Quantification of nine antiretroviral drugs in cerebrospinal fluid: An approach to overcome sample collection tube adsorption.
Mykris TM; Weinhold J; Winchester LC; Scarsi KK; Fletcher CV; Podany AT; Avedissian SN
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jul; 1227():123810. PubMed ID: 37429153
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the multiplexed quantification of etravirine, maraviroc, raltegravir, and rilpivirine in human plasma and tissue.
Parsons TL; Marzinke MA
J Pharm Biomed Anal; 2016 Nov; 131():333-344. PubMed ID: 27632783
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
[TBL] [Abstract][Full Text] [Related]
13. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G
J Pharm Biomed Anal; 2011 Mar; 54(4):779-88. PubMed ID: 21071165
[TBL] [Abstract][Full Text] [Related]
14. Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds.
Else L; Watson V; Tjia J; Hughes A; Siccardi M; Khoo S; Back D
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1455-65. PubMed ID: 20427248
[TBL] [Abstract][Full Text] [Related]
15. A liquid chromatography-tandem mass spectrometry assay for quantification of rilpivirine and dolutegravir in human plasma.
Grégoire M; Deslandes G; Renaud C; Bouquié R; Allavena C; Raffi F; Jolliet P; Dailly E
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():1-9. PubMed ID: 25261833
[TBL] [Abstract][Full Text] [Related]
16. Development, validation and clinical implementation of a UPLC-MS/MS bioanalytical method for simultaneous quantification of cabotegravir and rilpivirine E-isomer in human plasma.
Bevers LAH; van Ewijk-Beneken Kolmer EWJ; Te Brake HML; Burger DM
J Pharm Biomed Anal; 2024 Jan; 238():115832. PubMed ID: 37976991
[TBL] [Abstract][Full Text] [Related]
17. A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
Aouri M; Calmy A; Hirschel B; Telenti A; Buclin T; Cavassini M; Rauch A; Decosterd LA
J Mass Spectrom; 2013 May; 48(5):616-25. PubMed ID: 23674286
[TBL] [Abstract][Full Text] [Related]
18. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study.
Moreira FL; Marques MP; Duarte G; Lanchote VL
J Pharm Biomed Anal; 2020 Jan; 177():112838. PubMed ID: 31525573
[TBL] [Abstract][Full Text] [Related]
19. HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.
D'Avolio A; Siccardi M; Sciandra M; Baietto L; Bonora S; Trentini L; Di Perri G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(2):234-40. PubMed ID: 17964231
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: Application to human pharmacokinetics.
Reddy AV; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J; Madhavi G
J Sep Sci; 2015 Aug; 38(15):2580-7. PubMed ID: 25989063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
